About the Company
Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the food and biopharmaceutical industry. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods is able to maximize product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, O Olive Oil & Vinegar® premium artisan products and Yucatan® and Cabo Fresh® avocado products. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $LNDC News
What Made White Falcon Hold Lifecore Biomedical (LFCR)?
White Falcon Capital Management, an investment fund manager, released its first quarter 2024 investor letter. A copy of the ...
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
CHASKA, Minn., April 19, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: LFCR) (the “Company”) announced today that, on April 15, 2024, ...
Laughing Water Capital - Lifecore Biomedical: Getting Closer To Massive Improvements In Earnings Power
Lifecore Biomedical has been a frustrating investment to date with wild ups and downs. Why are we bullish LFCR? Click here to ...
Lifecore Biomedical (LFCR) Price Target Decreased by 11.11% to 8.16
Lifecore Biomedical Background Information (This description is provided by the company.) Landec Corporation is a leading ...
Cove Street Capital Q1 2024 Letter To Shareholders
We previously sold our direct equity ownership in the common stock of Lifecore Biomedical but continue with a large position ...
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation ...
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Lifecore Biomedical Inc. f/k/a Landec Corporation (NASDAQ ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCR
NEW YORK, NY / ACCESSWIRE / April 18, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Lifecore Biomedical, Inc. ("Lifecore" or the "Company") (NASDAQ:LFCR). Such investors are ...
Do You Believe in the Upside Trajectory of Lifecore Biomedical (LFCR)?
Cove Street Small Cap Value Fund featured stocks like Lifecore Biomedical, Inc. (NASDAQ:LFCR) in the first quarter 2024 ...
Joe Alwyn wanted to keep Taylor Swift relationship private
Joe Alwyn wanted to keep his six-year romance with Taylor Swift "personal". The 33-year-old actor and the 34-year-old ...
Joey King: I've had to grow up a little bit faster
Joey King feels she had to "grow up a little bit faster". The 24-year-old actress first found fame as a child, starring in ...
Lifecore Biomedical gets Nasdaq notice regarding delayed quarterly report
Lifecore Biomedical (NASDAQ:LFCR) on Friday said it received a letter from Nasdaq indicating that, as a result of the company’s delay in filing its quarterly report, Nasdaq would consider the ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Bancorp, Inc. - TBBK
NEW YORK, April 4, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Bancorp, Inc. ("TBBK" or the "Company") (NASDAQ: TBBK). Such investors are advised to ...
Loading the latest forecasts...